Assessment of fetal and placental blood flow in primates using contrast enhanced ultrasonography
Ultrasonographic contrast agents that stay within the vascular space and do not cross the placenta may permit differentiation between the maternal and fetal portions of the placenta and may be clinically useful for diagnosis of placental abnormalities. This study was performed to assess the effects...
Gespeichert in:
Veröffentlicht in: | Journal of ultrasound in medicine 1998-02, Vol.17 (2), p.75-80 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 80 |
---|---|
container_issue | 2 |
container_start_page | 75 |
container_title | Journal of ultrasound in medicine |
container_volume | 17 |
creator | Schmiedl, U. P Komarniski, K Winter, T. C Luna, J. A Cyr, D. R Ruppenthal, G Schlief, R |
description | Ultrasonographic contrast agents that stay within the vascular space and do not cross the placenta may permit differentiation between the maternal and fetal portions of the placenta and may be clinically useful for diagnosis of placental abnormalities. This study was performed to assess the effects of Levovist (Schering AG, Berlin) on the placental circulation and to determine whether hemodynamic effects on the fetus occur. Ten studies were performed in five pregnant macaques (median weight, 9.15 kg; range, 6.15 to 11 kg; median gestational age, 121 days; range, 34 days to term) under anesthesia. Gray scale, color, and duplex Doppler sonographic scans of the fetus and placenta were acquired using a 5 MHz curved array transducer. Fetal heart rate, resistive index, and systolic‐diastolic ratios were measured in the fetal middle cerebral artery, aorta, umbilical artery, and uterine artery before and after administration of contrast agent. The following dose regimen was tested: 5 ml of physiologic saline solution followed by 0.1 ml/kg of 300 mg/ml Levovist (diagnostic dose), 0.5 ml/kg of 400 mg/ml Levovist (maximum dose), and 5 ml physiologic saline solution. The order of diagnostic dose and maximal dose was randomized among animals. Color enhancement of the basal portions of the placenta was documented after administration of contrast agent. Heart rate and middle cerebral artery systolic‐diastolic ratio did not change between baseline and injections. A 7% decrease of the resistive index from baseline to maximum dose was measured in the uterine artery (not significant). A 7.7% decrease in the systolic‐diastolic ratio from baseline to maximum dose was recorded in the umbilical artery. However, an identical change was measured after saline solution was injected. The resistive index in the aorta increased by 2.6% from baseline to maximum dose, a change that was not significant (P > 0.5). Ultrasonographic contrast enhancement of the maternal circulation in placenta is demonstrated to be without significant effects on the fetal circulation as measured in this limited population. |
doi_str_mv | 10.7863/jum.1998.17.2.75 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79694408</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>321749</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4345-e27202336f9079c0afda2045114c18e6cc8f2b397dd981d30f40d2c52251e6cf3</originalsourceid><addsrcrecordid>eNqFkM1v1DAQxS1EVbaFOxckHxC3pP6MY25VBZSqiAs9G68_dlM59hIniva_r9MNvfZkzbzfzDw_AD5iVIu2oVePU19jKdsai5rUgr8BG8w5qmSD6VuwQUS0FSNSvAMXOT8iRBAW7BycS04EF80G_L3O2eXcuzjC5KF3ow5QRwsPQZvSLNU2pGShD2mGXYSHoev16DKcchd30KQ4DjqP0MW9jsZZOIWlkWLaDfqwP74HZ16H7D6s7yV4-P7tz81tdf_7x8-b6_vKMMp45YggiFDaeImENEh7qwliHGNmcOsaY1pPtlQKa2WLLUWeIUsMJ4Tjonp6Cb6c9h6G9G9yeVR9l40LQUeXpqyEbCRjqH0VJJhILvACohNohpTz4Lx6_vtwVBipJX1V0ldL-goLRZTgZeTTunva9s6-DKxxF_3zqutsdPBDiazLLxjBtG04K9jXEzZ3wR1fPavuHn4tNRbk2cN6Y9_t9nM3OJV7HUJxhNU8z_-tPgHB5azl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21295718</pqid></control><display><type>article</type><title>Assessment of fetal and placental blood flow in primates using contrast enhanced ultrasonography</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Schmiedl, U. P ; Komarniski, K ; Winter, T. C ; Luna, J. A ; Cyr, D. R ; Ruppenthal, G ; Schlief, R</creator><creatorcontrib>Schmiedl, U. P ; Komarniski, K ; Winter, T. C ; Luna, J. A ; Cyr, D. R ; Ruppenthal, G ; Schlief, R</creatorcontrib><description>Ultrasonographic contrast agents that stay within the vascular space and do not cross the placenta may permit differentiation between the maternal and fetal portions of the placenta and may be clinically useful for diagnosis of placental abnormalities. This study was performed to assess the effects of Levovist (Schering AG, Berlin) on the placental circulation and to determine whether hemodynamic effects on the fetus occur. Ten studies were performed in five pregnant macaques (median weight, 9.15 kg; range, 6.15 to 11 kg; median gestational age, 121 days; range, 34 days to term) under anesthesia. Gray scale, color, and duplex Doppler sonographic scans of the fetus and placenta were acquired using a 5 MHz curved array transducer. Fetal heart rate, resistive index, and systolic‐diastolic ratios were measured in the fetal middle cerebral artery, aorta, umbilical artery, and uterine artery before and after administration of contrast agent. The following dose regimen was tested: 5 ml of physiologic saline solution followed by 0.1 ml/kg of 300 mg/ml Levovist (diagnostic dose), 0.5 ml/kg of 400 mg/ml Levovist (maximum dose), and 5 ml physiologic saline solution. The order of diagnostic dose and maximal dose was randomized among animals. Color enhancement of the basal portions of the placenta was documented after administration of contrast agent. Heart rate and middle cerebral artery systolic‐diastolic ratio did not change between baseline and injections. A 7% decrease of the resistive index from baseline to maximum dose was measured in the uterine artery (not significant). A 7.7% decrease in the systolic‐diastolic ratio from baseline to maximum dose was recorded in the umbilical artery. However, an identical change was measured after saline solution was injected. The resistive index in the aorta increased by 2.6% from baseline to maximum dose, a change that was not significant (P > 0.5). Ultrasonographic contrast enhancement of the maternal circulation in placenta is demonstrated to be without significant effects on the fetal circulation as measured in this limited population.</description><identifier>ISSN: 0278-4297</identifier><identifier>EISSN: 1550-9613</identifier><identifier>DOI: 10.7863/jum.1998.17.2.75</identifier><identifier>PMID: 9527576</identifier><identifier>CODEN: JUMEDA</identifier><language>eng</language><publisher>Laurel, MD: Am inst Ulrrasound Med</publisher><subject>Analysis of Variance ; Animals ; Aorta - diagnostic imaging ; Arteries ; Biological and medical sciences ; Blood vessels ; Cerebral Arteries - diagnostic imaging ; Contrast media ; Contrast Media - administration & dosage ; Diastole ; Female ; Fetal Blood ; Fetal monitoring ; Fetus - blood supply ; Gestational Age ; Gynecology. Andrology. Obstetrics ; Heart Rate ; Heart Rate, Fetal ; Hemodynamics ; Image Enhancement ; Living systems studies ; Macaca nemestrina ; Management. Prenatal diagnosis ; Medical imaging ; Medical sciences ; Neurophysiology ; Physiological models ; Placenta - blood supply ; Placenta - diagnostic imaging ; Placenta Diseases - diagnostic imaging ; Polysaccharides - administration & dosage ; Pregnancy - blood ; Pregnancy. Fetus. Placenta ; Random Allocation ; Regional Blood Flow ; Sodium Chloride ; Systole ; Ultrasonography, Doppler, Color ; Ultrasonography, Doppler, Duplex ; Ultrasonography, Prenatal ; Umbilical Arteries - diagnostic imaging ; Uterus - blood supply ; Vascular Resistance</subject><ispartof>Journal of ultrasound in medicine, 1998-02, Vol.17 (2), p.75-80</ispartof><rights>2016 by the American Institute of Ultrasound in Medicine</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4345-e27202336f9079c0afda2045114c18e6cc8f2b397dd981d30f40d2c52251e6cf3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.7863%2Fjum.1998.17.2.75$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.7863%2Fjum.1998.17.2.75$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2138654$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9527576$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schmiedl, U. P</creatorcontrib><creatorcontrib>Komarniski, K</creatorcontrib><creatorcontrib>Winter, T. C</creatorcontrib><creatorcontrib>Luna, J. A</creatorcontrib><creatorcontrib>Cyr, D. R</creatorcontrib><creatorcontrib>Ruppenthal, G</creatorcontrib><creatorcontrib>Schlief, R</creatorcontrib><title>Assessment of fetal and placental blood flow in primates using contrast enhanced ultrasonography</title><title>Journal of ultrasound in medicine</title><addtitle>J Ultrasound Med</addtitle><description>Ultrasonographic contrast agents that stay within the vascular space and do not cross the placenta may permit differentiation between the maternal and fetal portions of the placenta and may be clinically useful for diagnosis of placental abnormalities. This study was performed to assess the effects of Levovist (Schering AG, Berlin) on the placental circulation and to determine whether hemodynamic effects on the fetus occur. Ten studies were performed in five pregnant macaques (median weight, 9.15 kg; range, 6.15 to 11 kg; median gestational age, 121 days; range, 34 days to term) under anesthesia. Gray scale, color, and duplex Doppler sonographic scans of the fetus and placenta were acquired using a 5 MHz curved array transducer. Fetal heart rate, resistive index, and systolic‐diastolic ratios were measured in the fetal middle cerebral artery, aorta, umbilical artery, and uterine artery before and after administration of contrast agent. The following dose regimen was tested: 5 ml of physiologic saline solution followed by 0.1 ml/kg of 300 mg/ml Levovist (diagnostic dose), 0.5 ml/kg of 400 mg/ml Levovist (maximum dose), and 5 ml physiologic saline solution. The order of diagnostic dose and maximal dose was randomized among animals. Color enhancement of the basal portions of the placenta was documented after administration of contrast agent. Heart rate and middle cerebral artery systolic‐diastolic ratio did not change between baseline and injections. A 7% decrease of the resistive index from baseline to maximum dose was measured in the uterine artery (not significant). A 7.7% decrease in the systolic‐diastolic ratio from baseline to maximum dose was recorded in the umbilical artery. However, an identical change was measured after saline solution was injected. The resistive index in the aorta increased by 2.6% from baseline to maximum dose, a change that was not significant (P > 0.5). Ultrasonographic contrast enhancement of the maternal circulation in placenta is demonstrated to be without significant effects on the fetal circulation as measured in this limited population.</description><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Aorta - diagnostic imaging</subject><subject>Arteries</subject><subject>Biological and medical sciences</subject><subject>Blood vessels</subject><subject>Cerebral Arteries - diagnostic imaging</subject><subject>Contrast media</subject><subject>Contrast Media - administration & dosage</subject><subject>Diastole</subject><subject>Female</subject><subject>Fetal Blood</subject><subject>Fetal monitoring</subject><subject>Fetus - blood supply</subject><subject>Gestational Age</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Heart Rate</subject><subject>Heart Rate, Fetal</subject><subject>Hemodynamics</subject><subject>Image Enhancement</subject><subject>Living systems studies</subject><subject>Macaca nemestrina</subject><subject>Management. Prenatal diagnosis</subject><subject>Medical imaging</subject><subject>Medical sciences</subject><subject>Neurophysiology</subject><subject>Physiological models</subject><subject>Placenta - blood supply</subject><subject>Placenta - diagnostic imaging</subject><subject>Placenta Diseases - diagnostic imaging</subject><subject>Polysaccharides - administration & dosage</subject><subject>Pregnancy - blood</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Random Allocation</subject><subject>Regional Blood Flow</subject><subject>Sodium Chloride</subject><subject>Systole</subject><subject>Ultrasonography, Doppler, Color</subject><subject>Ultrasonography, Doppler, Duplex</subject><subject>Ultrasonography, Prenatal</subject><subject>Umbilical Arteries - diagnostic imaging</subject><subject>Uterus - blood supply</subject><subject>Vascular Resistance</subject><issn>0278-4297</issn><issn>1550-9613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM1v1DAQxS1EVbaFOxckHxC3pP6MY25VBZSqiAs9G68_dlM59hIniva_r9MNvfZkzbzfzDw_AD5iVIu2oVePU19jKdsai5rUgr8BG8w5qmSD6VuwQUS0FSNSvAMXOT8iRBAW7BycS04EF80G_L3O2eXcuzjC5KF3ow5QRwsPQZvSLNU2pGShD2mGXYSHoev16DKcchd30KQ4DjqP0MW9jsZZOIWlkWLaDfqwP74HZ16H7D6s7yV4-P7tz81tdf_7x8-b6_vKMMp45YggiFDaeImENEh7qwliHGNmcOsaY1pPtlQKa2WLLUWeIUsMJ4Tjonp6Cb6c9h6G9G9yeVR9l40LQUeXpqyEbCRjqH0VJJhILvACohNohpTz4Lx6_vtwVBipJX1V0ldL-goLRZTgZeTTunva9s6-DKxxF_3zqutsdPBDiazLLxjBtG04K9jXEzZ3wR1fPavuHn4tNRbk2cN6Y9_t9nM3OJV7HUJxhNU8z_-tPgHB5azl</recordid><startdate>199802</startdate><enddate>199802</enddate><creator>Schmiedl, U. P</creator><creator>Komarniski, K</creator><creator>Winter, T. C</creator><creator>Luna, J. A</creator><creator>Cyr, D. R</creator><creator>Ruppenthal, G</creator><creator>Schlief, R</creator><general>Am inst Ulrrasound Med</general><general>American Institute of Ultrasound in Medicine</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199802</creationdate><title>Assessment of fetal and placental blood flow in primates using contrast enhanced ultrasonography</title><author>Schmiedl, U. P ; Komarniski, K ; Winter, T. C ; Luna, J. A ; Cyr, D. R ; Ruppenthal, G ; Schlief, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4345-e27202336f9079c0afda2045114c18e6cc8f2b397dd981d30f40d2c52251e6cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Aorta - diagnostic imaging</topic><topic>Arteries</topic><topic>Biological and medical sciences</topic><topic>Blood vessels</topic><topic>Cerebral Arteries - diagnostic imaging</topic><topic>Contrast media</topic><topic>Contrast Media - administration & dosage</topic><topic>Diastole</topic><topic>Female</topic><topic>Fetal Blood</topic><topic>Fetal monitoring</topic><topic>Fetus - blood supply</topic><topic>Gestational Age</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Heart Rate</topic><topic>Heart Rate, Fetal</topic><topic>Hemodynamics</topic><topic>Image Enhancement</topic><topic>Living systems studies</topic><topic>Macaca nemestrina</topic><topic>Management. Prenatal diagnosis</topic><topic>Medical imaging</topic><topic>Medical sciences</topic><topic>Neurophysiology</topic><topic>Physiological models</topic><topic>Placenta - blood supply</topic><topic>Placenta - diagnostic imaging</topic><topic>Placenta Diseases - diagnostic imaging</topic><topic>Polysaccharides - administration & dosage</topic><topic>Pregnancy - blood</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Random Allocation</topic><topic>Regional Blood Flow</topic><topic>Sodium Chloride</topic><topic>Systole</topic><topic>Ultrasonography, Doppler, Color</topic><topic>Ultrasonography, Doppler, Duplex</topic><topic>Ultrasonography, Prenatal</topic><topic>Umbilical Arteries - diagnostic imaging</topic><topic>Uterus - blood supply</topic><topic>Vascular Resistance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schmiedl, U. P</creatorcontrib><creatorcontrib>Komarniski, K</creatorcontrib><creatorcontrib>Winter, T. C</creatorcontrib><creatorcontrib>Luna, J. A</creatorcontrib><creatorcontrib>Cyr, D. R</creatorcontrib><creatorcontrib>Ruppenthal, G</creatorcontrib><creatorcontrib>Schlief, R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of ultrasound in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schmiedl, U. P</au><au>Komarniski, K</au><au>Winter, T. C</au><au>Luna, J. A</au><au>Cyr, D. R</au><au>Ruppenthal, G</au><au>Schlief, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of fetal and placental blood flow in primates using contrast enhanced ultrasonography</atitle><jtitle>Journal of ultrasound in medicine</jtitle><addtitle>J Ultrasound Med</addtitle><date>1998-02</date><risdate>1998</risdate><volume>17</volume><issue>2</issue><spage>75</spage><epage>80</epage><pages>75-80</pages><issn>0278-4297</issn><eissn>1550-9613</eissn><coden>JUMEDA</coden><abstract>Ultrasonographic contrast agents that stay within the vascular space and do not cross the placenta may permit differentiation between the maternal and fetal portions of the placenta and may be clinically useful for diagnosis of placental abnormalities. This study was performed to assess the effects of Levovist (Schering AG, Berlin) on the placental circulation and to determine whether hemodynamic effects on the fetus occur. Ten studies were performed in five pregnant macaques (median weight, 9.15 kg; range, 6.15 to 11 kg; median gestational age, 121 days; range, 34 days to term) under anesthesia. Gray scale, color, and duplex Doppler sonographic scans of the fetus and placenta were acquired using a 5 MHz curved array transducer. Fetal heart rate, resistive index, and systolic‐diastolic ratios were measured in the fetal middle cerebral artery, aorta, umbilical artery, and uterine artery before and after administration of contrast agent. The following dose regimen was tested: 5 ml of physiologic saline solution followed by 0.1 ml/kg of 300 mg/ml Levovist (diagnostic dose), 0.5 ml/kg of 400 mg/ml Levovist (maximum dose), and 5 ml physiologic saline solution. The order of diagnostic dose and maximal dose was randomized among animals. Color enhancement of the basal portions of the placenta was documented after administration of contrast agent. Heart rate and middle cerebral artery systolic‐diastolic ratio did not change between baseline and injections. A 7% decrease of the resistive index from baseline to maximum dose was measured in the uterine artery (not significant). A 7.7% decrease in the systolic‐diastolic ratio from baseline to maximum dose was recorded in the umbilical artery. However, an identical change was measured after saline solution was injected. The resistive index in the aorta increased by 2.6% from baseline to maximum dose, a change that was not significant (P > 0.5). Ultrasonographic contrast enhancement of the maternal circulation in placenta is demonstrated to be without significant effects on the fetal circulation as measured in this limited population.</abstract><cop>Laurel, MD</cop><pub>Am inst Ulrrasound Med</pub><pmid>9527576</pmid><doi>10.7863/jum.1998.17.2.75</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0278-4297 |
ispartof | Journal of ultrasound in medicine, 1998-02, Vol.17 (2), p.75-80 |
issn | 0278-4297 1550-9613 |
language | eng |
recordid | cdi_proquest_miscellaneous_79694408 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Analysis of Variance Animals Aorta - diagnostic imaging Arteries Biological and medical sciences Blood vessels Cerebral Arteries - diagnostic imaging Contrast media Contrast Media - administration & dosage Diastole Female Fetal Blood Fetal monitoring Fetus - blood supply Gestational Age Gynecology. Andrology. Obstetrics Heart Rate Heart Rate, Fetal Hemodynamics Image Enhancement Living systems studies Macaca nemestrina Management. Prenatal diagnosis Medical imaging Medical sciences Neurophysiology Physiological models Placenta - blood supply Placenta - diagnostic imaging Placenta Diseases - diagnostic imaging Polysaccharides - administration & dosage Pregnancy - blood Pregnancy. Fetus. Placenta Random Allocation Regional Blood Flow Sodium Chloride Systole Ultrasonography, Doppler, Color Ultrasonography, Doppler, Duplex Ultrasonography, Prenatal Umbilical Arteries - diagnostic imaging Uterus - blood supply Vascular Resistance |
title | Assessment of fetal and placental blood flow in primates using contrast enhanced ultrasonography |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T17%3A41%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20fetal%20and%20placental%20blood%20flow%20in%20primates%20using%20contrast%20enhanced%20ultrasonography&rft.jtitle=Journal%20of%20ultrasound%20in%20medicine&rft.au=Schmiedl,%20U.%20P&rft.date=1998-02&rft.volume=17&rft.issue=2&rft.spage=75&rft.epage=80&rft.pages=75-80&rft.issn=0278-4297&rft.eissn=1550-9613&rft.coden=JUMEDA&rft_id=info:doi/10.7863/jum.1998.17.2.75&rft_dat=%3Cproquest_cross%3E321749%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21295718&rft_id=info:pmid/9527576&rfr_iscdi=true |